Literature DB >> 12602561

Protons to replace photons in external beam radiation therapy?

H D Suit1.   

Abstract

Protons provide the basis for superior distribution of radiation dose due to the physical characteristics of protons. Proton beams used in radiation therapy can be designed to yield a uniform dose across the target and then virtually zero deep to the target and lower dose proximal to the target (for non-superficial lesions). Such beams can be employed in comparable number, direction, weighting, angulation, intensity modulation as is feasible for photon beams. The result is a smaller treatment volume, and hence a lower incidence and frequency of treatment-related morbidity. Importantly, the reduction in treatment volume permits a higher dose to the tumour. This means an improved tumour control probability and lower normal tissue complication probability. Clinical gains appear to have been realized in the treatment of patient with uveal melanoma, skull-base sarcoma, para-nasal sinus carcinomas, selected stages of lung carcinoma and hepatocellular carcinoma. There are now three proton therapy centres with gantry systems with seven more being built. Further, there are seven additional centres in active planning. At present, prospective clinical evaluations are in progress for tumours at many anatomical sites.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12602561     DOI: 10.1053/clon.2002.0171

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  7 in total

1.  Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma.

Authors:  Henrike Wuestemeyer; Wolfgang Sauerwein; Daniel Meller; Pierre Chauvel; Andreas Schueler; Klaus-Peter Steuhl; Norbert Bornfeld; Gerasimos Anastassiou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-23       Impact factor: 3.117

2.  Effects of selenomethionine in irradiated human thyroid epithelial cells and tumorigenicity studies.

Authors:  Jeffrey H Ware; Zhaozong Zhou; Ana L Romero-Weaver; X Steven Wan; Paul M Newberne; Ann R Kennedy
Journal:  Nutr Cancer       Date:  2011-09-14       Impact factor: 2.900

3.  Dosimetric feasibility of real-time MRI-guided proton therapy.

Authors:  M Moteabbed; J Schuemann; H Paganetti
Journal:  Med Phys       Date:  2014-11       Impact factor: 4.071

4.  The risk of developing a second cancer after receiving craniospinal proton irradiation.

Authors:  Wayne D Newhauser; Jonas D Fontenot; Anita Mahajan; David Kornguth; Marilyn Stovall; Yuanshui Zheng; Phillip J Taddei; Dragan Mirkovic; Radhe Mohan; James D Cox; Shiao Woo
Journal:  Phys Med Biol       Date:  2009-03-20       Impact factor: 3.609

5.  Reirradiation for Recurrent Scalp Angiosarcoma: Dosimetric Advantage of PBT over VMAT and EBT.

Authors:  Tal Eitan; Nicholas J Damico; Rajesh Pidikiti; Michael Z Kharouta; Donald Dobbins; Frederick B Jesseph; Mark Smith; Ankit Mangla; Theodoros N Teknos; David B Mansur; Mitchell Machtay; Min Yao; Aashish D Bhatt
Journal:  Int J Part Ther       Date:  2019-12-16

6.  Proton radiotherapy dose perturbations caused by esophageal stents of varying material composition are negligible in an experimental model.

Authors:  Sujai Jalaj; Sang Yeob Lee; Camille McGaw; Bijo K John; Zuofeng Li; Ziad T Awad; James S Scolapio; Juan C Munoz
Journal:  Endosc Int Open       Date:  2014-10-24

7.  Mixed integer programming with dose-volume constraints in intensity-modulated proton therapy.

Authors:  Pengfei Zhang; Neng Fan; Jie Shan; Steven E Schild; Martin Bues; Wei Liu
Journal:  J Appl Clin Med Phys       Date:  2017-07-06       Impact factor: 2.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.